Research compendium
SHLP-2
SHLP-2 belongs to the small humanin-like peptide family, whose identification was linked to a mitochondrial DNA region. It has been studied in cellular metabolism and mitochondrial-damage models. Family membership does not make it humanin or establish properties shared by every member.
This is a research reference, not a product offered in the Asciende catalog. Published studies do not establish the identity, purity or availability of a commercial preparation.
Sequence origin and measured compartment
Do not turn a name’s origin into a localization or function claim. Preserve the specific evidence connecting sequence, detection and response.
- Does the work distinguish a proposed sequence, detected peptide and synthesized material?
- Which compartment or model supplies the signal being interpreted?
- Is the functional readout compared with appropriate system controls?
Mechanism described in the literature
In human ARPE-19 transmitochondrial cells in vitro, SHLP-2 was associated with changes in oxidative-phosphorylation components and viability. These integrated cellular readings do not alone identify a direct receptor or a complete causal chain.
Classification
Peptide derived from a mitochondrial-genome region
Other names
- SHLP2
- Small humanin-like peptide 2
A family requiring individual evaluation
Initial research compared several SHLPs and found different cellular profiles. The common name organizes a research family rather than replacing comparison. SHLP-2 evidence must remain distinct from SHLP-3 results despite their similar names.
What the transmitochondrial model contributes
The retinal study used human ARPE-19 cells in a transmitochondrial design related to macular degeneration. In vitro, SHLP-2 attenuated viability and mitochondrial-marker abnormalities. The model isolates mitochondrial differences in a defined cellular context, but represents neither a complete retina nor a vision measurement.
Respiratory proteins and function are different readings
Respiratory-subunit abundance, mitochondrial DNA copy number and survival are distinct variables. Reporting them separately avoids calling every change global mitochondrial recovery. Responses to added SHLP-2 also do not establish endogenous peptide quantities in tissue.
Questions and answers
Does the ARPE-19 study demonstrate changes in vision?
No. It evaluated cells and mitochondrial markers, not visual function in people.
Is SHLP-2 another name for humanin?
No. It is a distinct entity in a related research line.
Sources
- Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. — Aging (Albany NY) (2016); PMID 27070352; DOI 10.18632/aging.100943
- Naturally occurring mitochondrial-derived peptides are age-dependent regulators of apoptosis, insulin sensitivity, and inflammatory markers. — Aging (Albany NY) (2016); PMID 27070352; DOI 10.18632/aging.100943
- Characterizing the protective effects of SHLP2, a mitochondrial-derived peptide, in macular degeneration. — Sci Rep (2018); PMID 30310092; DOI 10.1038/s41598-018-33290-5
- Characterizing the protective effects of SHLP2, a mitochondrial-derived peptide, in macular degeneration. — Sci Rep (2018); PMID 30310092; DOI 10.1038/s41598-018-33290-5